1. Godman GC, Churg J. Wegener's granulomatosis: pathology and review of the literature. AMA Arch Pathol. 1954; 58:533–553.
2. Duna GF, Galperin C, Hoffman GS. Wegener's granulomatosis. Rheum Dis Clin North Am. 1995; 21:949–986.
Article
3. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990; 33:1101–1107.
Article
4. Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985; 23:425–429.
Article
5. Spoerl D, Pers YM, Jorgensen C. Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: two case reports and review of literature. Allergy Asthma Clin Immunol. 2012; 8:19.
Article
6. Szilasi M, Mátyus J, File I, Szücs G, Rákóczi E, Pfliegler G, et al. Association of ANCA-associated vasculitis-rheumatoid arthritis overlap syndrome in four patients: rituximab may be the right choice? Autoimmunity. 2012; 45:304–309.
Article
7. Sturrock RD, Ratnesar P. Wegener's granulomatosis occurring in a patient with pre-existing rheumatoid arthritis. Br J Clin Pract. 1974; 28:183–184.
8. Ohashi H, Itoh M, Ogawa N, Sudo Y, Endo S, Okugawa T, et al. Wegener's granulomatosis in a patient with a rheumatoid arthritis. Intern Med. 1992; 31:1128–1131.
Article
9. Schwarz-Eywill M, Mantaka P, Unger L, Wittek A, Nüsslein H. First-time manifestation of generalized Wegener's granulomatosis despite methotrexate. Br J Rheumatol. 1998; 37:344–345.
Article
10. Chinoy H, McKenna F. Wegener's granulomatosis and rheumatoid arthritis overlap. Rheumatology (Oxford). 2002; 41:588–589.
Article
11. Douglas G, Bird K, Flume P, Silver R, Bolster M. Wegener's granulomatosis in patients with rheumatoid arthritis. J Rheumatol. 2003; 30:2064–2069.
12. Pai S, Panda M. Limited Wegener's granulomatosis presenting as lung nodules in a patient with rheumatoid arthritis: a case report. Cases J. 2008; 1:417.
Article
13. Broshtilova V, Iliev E, Gantcheva M. Etanercept-induced Wegener granulomatosis in a patient with rheumatoid arthritis. Dermatol Ther. 2013; 26(1):73–76.
Article
14. Jagiello P, Aries P, Arning L, Wagenleiter SE, Csernok E, Hellmich B, et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum. 2005; 52:4039–4043.
Article
15. Chung SA, Xie G, Roshandel D, Sherva R, Edberg JC, Kravitz M, et al. Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis. Arthritis Rheum. 2012; 64:3463–3471.
Article
16. Hemminki K, Li X, Sundquist J, Sundquist K. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum. 2009; 60:661–668.
Article
17. Radice A, Bianchi L, Sinico RA. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev. 2013; 12:487–495.
Article
18. Schmitt WH, van der Woude FJ. Clinical applications of antineutrophil cytoplasmic antibody testing. Curr Opin Rheumatol. 2004; 16:9–17.
Article
19. Pagnoux C, Seror R, Bérezné A, Rouabhia S, Goulvestre C, Guillevin L. Remittent non-destructive polysynovitis in P-ANCA-positive vasculitis patients with anti-CCP antibodies. Joint Bone Spine. 2010; 77:604–607.
Article
20. Mustila A, Korpela M, Mustonen J, Helin H, Huhtala H, Soppi E, et al. Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: a marker of severe disease with associated nephropathy. Arthritis Rheum. 1997; 40:710–717.
Article
21. Jearn LH, Kim TY. Reevaluation of antineutrophil cytoplasmic antibodies. J Korean Rheum Assoc. 2004; 11:52–56.
22. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int. 1998; 53:743–753.
Article